Literature DB >> 35012324

RNA Modification Signature of Peripheral Blood as a Potential Diagnostic Marker for Pulmonary Hypertension.

Liwen Zhang1,2, Yuzhu Li3, Jian Wang3, Cheng Hong3, Wenju Lu3, Yongcun Qu1,2, Stephen M Black4, Qi Chen5, Tong Zhou6, Wanzhu Jin1, Enkui Duan1,7, Haiyang Tang3,8, Ying Zhang9.   

Abstract

Entities:  

Keywords:  biomarkers; hemodynamics; lung; mass spectrometry; pulmonary hypertension; ribonucleosides

Mesh：

Substances：

Year:  2022        PMID： 35012324      PMCID： PMC9403405          DOI： 10.1161/HYPERTENSIONAHA.121.18724

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   9.897


× No keyword cloud information.
  5 in total

1.  Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study.

Authors:  Roderick C Deaño; Cherylanne Glassner-Kolmin; Melvyn Rubenfire; Adaani Frost; Scott Visovatti; Vallerie V McLaughlin; Mardi Gomberg-Maitland
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

2.  Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysis.

Authors:  Kurt W Prins; Sue Duval; Jeremy Markowitz; Marc Pritzker; Thenappan Thenappan
Journal:  Pulm Circ       Date:  2017-03-24       Impact factor: 3.017

3.  Pulmonary hypertension in chronic lung disease and hypoxia.

Authors:  Steven D Nathan; Joan A Barbera; Sean P Gaine; Sergio Harari; Fernando J Martinez; Horst Olschewski; Karen M Olsson; Andrew J Peacock; Joanna Pepke-Zaba; Steeve Provencher; Norbert Weissmann; Werner Seeger
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

4.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; David Montani; David S Celermajer; Christopher P Denton; Michael A Gatzoulis; Michael Krowka; Paul G Williams; Rogerio Souza
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

5.  Dnmt2 mediates intergenerational transmission of paternally acquired metabolic disorders through sperm small non-coding RNAs.

Authors:  Yunfang Zhang; Xudong Zhang; Junchao Shi; Francesca Tuorto; Xin Li; Yusheng Liu; Reinhard Liebers; Liwen Zhang; Yongcun Qu; Jingjing Qian; Maya Pahima; Ying Liu; Menghong Yan; Zhonghong Cao; Xiaohua Lei; Yujing Cao; Hongying Peng; Shichao Liu; Yue Wang; Huili Zheng; Rebekah Woolsey; David Quilici; Qiwei Zhai; Lei Li; Tong Zhou; Wei Yan; Frank Lyko; Ying Zhang; Qi Zhou; Enkui Duan; Qi Chen
Journal:  Nat Cell Biol       Date:  2018-04-25       Impact factor: 28.824
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.